Skip to main content

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

Feedback
Newsletter
RSS
Twitter

User Top Menu

Welcome, guest
Log In
Join
Why Join?

Search form

Search

About Us
- Overview
- Who We Are
- Contact
- Fan Mail
- How to Cite
News & Future Directions
Papers
Forums
- Discussions
- Webinars
Professional Resources
Research Resources
Click Here to Support MSDF

You are here

Most Viewed

Histological correlation of diffusional kurtosis and white matter modeling metrics in cuprizone-induced corpus callosum demyelination.
Fingolimod attenuates splenocyte-induced demyelination in cerebellar slice cultures.
Life on hold: the experience of living with neuromyelitis optica.
5-HT2 RECEPTORS FACILITATE JC POLYOMAVIRUS ENTRY.
Successful treatment for neuromyelitis optica with systemic lupus erythematosus.
Colour vision impairment is associated with disease severity in multiple sclerosis.
Novartis MS pill heads stream of SMC approvals
The possible efficacy of artichoke in fluconazole related hepatotoxicity.
[Treatment of multiple sclerosis symptoms and exacerbations].
Comparison of Routine Brain Imaging at 3 T and 7 T.
Aggregation Kinetics for IgG1-Based Monoclonal Antibody Therapeutics.
Early P2X7R-related astrogliosis in autoimmune encephalomyelitis.
Reduced Myelin Water in the White Matter Tracts of Patients with Niemann-Pick Disease Type C.
ENDOCANNABINOID SYSTEM: A multi-facet therapeutic target.
The Standards of Reporting of Neurological Disorders (STROND) checklist: Application to multiple sclerosis.
Correction: Comparative Study on the Therapeutic Potential of Neurally Differentiated Stem Cells in a Mouse Model of Multiple Sclerosis.
[Clinical significance of the cardiovascular effects of fingolimod treatment in multiple sclerosis].
Mimics and rare presentations of pediatric demyelination.
Association of SNPs of CD40 Gene with Multiple Sclerosis in Russians.
Gait disorders in multiple sclerosis.
Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases.
[Cognitive deficits and dementia in patients with multiple sclerosis: status quo and open questions].
Caregiver burden, quality of life and walking ability in different disability levels of multiple sclerosis.
Myeloid cells as target of fingolimod action in multiple sclerosis.
NDRG2 promoted secreted miR-375 in microvesicles shed from M1 microglia, which induced neuron damage.

Pages

« first
‹ previous
…
385
386
387
388
389
390
391
392
393
…
next ›
last »

MSDF Footer

Copyright © 2014 MGH and ACP

Privacy
Terms of Use
How to Cite
FAQ/Help
Site Map
Support Us
Feedback
Image Credits

All site content, except where otherwise noted, is licensed under a Creative Commons BY license. Please let us know where and how you use MSDF material.

Content By

Software By